Post by Irving Oil

“You’re never just treating cancer — you’re treating the patient, their family and the loved ones around them.” Dr. Ephraim Hochberg believes strongly in the impact of treating a patient's entire medical journey. At Mass General Brigham, where he is the Executive Vice Chair or Hematology Oncology, that belief extends beyond individual care — it is part of a broader mission as a world-leading integrated healthcare system advancing discoveries that benefit patients globally. Earlier this year, Irving Oil announced a $35‑million gift to Massachusetts General Hospital, inspired by the legacy of our company’s late Chairman Emeritus Arthur L. Irving. “We’re very proud of our ability to develop new chemotherapy drugs that set a standard for international care,” Dr. Hochberg said. “Over more than three decades of collaboration with MGH, Mr. Irving was a staunch advocate for the hospital’s mission." This renowned institution is home to groundbreaking research that goes beyond borders and helps world-leading cancer, heart and vascular institutes, as well as advanced clinical treatment offerings and commitment to innovation. The impact of Irving Oil’s transformative gift supports innovation in cancer care that benefits patients in Boston, across Canada and around the world. By investing in world-class care and research, these investments are far-reaching in their impact. Thank you, Dr. Hochberg and the many dedicated medical staff at hospitals across our geographies for the care you bring to our communities.